Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
Nichols KE, Levitz S, Shannon KE, Wahrer DC, Bell DW, Chang G, Hegde S, Neuberg D, Shafman T, Tarbell NJ, Mauch P, Ishioka C, Haber DA, Diller L.
Nichols KE, et al. Among authors: mauch p.
J Clin Oncol. 1999 Apr;17(4):1259. doi: 10.1200/JCO.1999.17.4.1259.
J Clin Oncol. 1999.
PMID: 10561187